Standout Papers

Targeting metabolic dysregulation for fibrosis therapy 2019 2026 2021 2023 325
  1. Targeting metabolic dysregulation for fibrosis therapy (2019)
    Xiao Zhao, Jennifer Kwan et al. Nature Reviews Drug Discovery

Immediate Impact

56 standout
Sub-graph 1 of 21

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
2 intermediate papers

Works of Jennifer Kwan being referenced

Targeting metabolic dysregulation for fibrosis therapy
2019 Standout

Author Peers

Author Last Decade Papers Cites
Jennifer Kwan 136 90 208 156 32 793
Elizabeth Shaughnessy 207 63 193 126 46 939
Anne Rigg 362 47 204 155 36 931
Candace L. Haddox 272 39 208 170 30 894
Michelle Moghadassi 193 218 208 153 31 967
Vivian Y. Chang 101 39 313 129 42 966
R.P. Symonds 203 225 208 176 35 805
Suzanne Cole 125 46 154 129 52 664
Ali Dabaja 136 32 252 211 53 856
Jessica M. Faupel‐Badger 250 53 180 82 47 956
Van Dinh Tran 275 100 146 106 52 871

All Works

Loading papers...

Rankless by CCL
2026